The organizational set up of various functionaries in Drugs and Control Administration are broadly classified into two wings.

    1. Enforcement Wing 2. Laboratory Wing.

    Enforcement Wing performs the functions of enforcement of the above legislations in the State and Laboratory Wing performs the Test/Analysis of various Drugs/Cosmetics samples sent for analysis and issues the Certificate of Test/Analysis.

    In 1976, FDA was carved out from the Directorate of Medical and Health, headed by an IPS Officer till 1981. Drugs Control Administration, A.P was separated from the office of the Drugs Controller & State Food Health Authority in the year 1981 and was made an independent Department headed by Director, DCA till 1996.

    In Aug 1996, Govt. had posted an IPS officer of the rank of Inspector General of Police, Drugs and Copyright to head the DCA. Subsequently this post was upgraded to ADGP/DGP level as the HOD.

    After the bifurcation of erstwhile Andhra Pradesh state, the Drugs Control Administration department of Telangana State was setup on 02.06.2014.

  • Registration of non-notified Medical Devices is MANDATORY w.e.f. 01 October 2021 for all the manufacturers and importers. Step-by-step procedure for Registration and Guidance Document in this regard.

  • Direction under Section 33P of the Drugs and Cosmetics Act 1940 for issuance of clarification on Stem Cell derived products as defined under New Drugs and Clinical Trial Rules, 2019 - Communicated.

  • Hand Sanitizers - Requirements to be met by the applicant firms

  • Circular issued to Industrial Oxygen Manufacturers in Telangana regarding granting of permissions to ensure adequate supply and availability of Medical Oxygen in view of COVID-19

  • Advisory for maintaining safe and adequate blood supply during the pandemic outbreak of COVID-19 issued to Blood Banks in Telangana State

  • Advisory for regulating sale and distribution of Masks in view of COVID-19 - issued to Chemists and Druggists of Telangana State

  • Visit HOW TO APPLY tab of main menu for Checklists of Applications, fees structure and proforma
  • Procedure to the followed for subsequent applicant in respect of FDCs declared as rational by Prof. Kokate Committee and approved by DCGI

  • DCGI Circular regarding submission of Stability Data along with application for grant of licence for drugs

  • Guideline issued by CDSCO for uploading manufacturing sites and formulation data on the SUGAM Portal by manufacturers

  • Circular issued regarding certain instructions on sale of Oxytocin

  • GO issued regarding amendment of Maximum Response Time for online application process for Grant of licenses and Omission of Renewal of Licences from GO Ms No 103 dated 21-06-2017

  • GO issued regarding Online Application process for Issue or Renewal of Licenses Ease of Doing Business 2017


  • COVID-19 Status



    odlshelpdesk.ts@gmail.com

    Main Menu

    Public Services

      Your are Visitor #297799